熱門資訊> 正文
Sana Biotechnology非GAAP每股收益为-0.39美元
2025-08-12 04:45
- Sana Biotechnology, Inc.(SANA) 0
- Cambria Global Asset Allocation ETF(GAA) 0
- WisdomTree Earnings 500 Fund(EPS) 0
- Sana Biotechnology press release (NASDAQ:SANA): Q2 Non-GAAP EPS of -$0.39.
- Cash, cash equivalents, and marketable securities as of June 30, 2025 were $72.7 million compared to $152.5 million as of December 31, 2024. The decrease of $79.8 million was primarily driven by cash used in operations of $81.8 million.
More on Sana Biotechnology
- Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued
- Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment
- Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35
- Seeking Alpha’s Quant Rating on Sana Biotechnology
- Historical earnings data for Sana Biotechnology
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
